Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-24

Clinical Trial Update: Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of pirfenidone capsules for pneumoconiosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Pneumoconiosis | Phase 3 | Status: RECRUITING